AU5088690A - Keratoconjunctivitis cytotoxin and methods for its use and production - Google Patents

Keratoconjunctivitis cytotoxin and methods for its use and production

Info

Publication number
AU5088690A
AU5088690A AU50886/90A AU5088690A AU5088690A AU 5088690 A AU5088690 A AU 5088690A AU 50886/90 A AU50886/90 A AU 50886/90A AU 5088690 A AU5088690 A AU 5088690A AU 5088690 A AU5088690 A AU 5088690A
Authority
AU
Australia
Prior art keywords
keratoconjunctivitis
cytotoxin
production
methods
keratoconjunctivitis cytotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50886/90A
Inventor
Lisle W. George
George M. Kagonyera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU5088690A publication Critical patent/AU5088690A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU50886/90A 1989-01-06 1990-01-05 Keratoconjunctivitis cytotoxin and methods for its use and production Abandoned AU5088690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29423989A 1989-01-06 1989-01-06
US294239 1999-04-19

Publications (1)

Publication Number Publication Date
AU5088690A true AU5088690A (en) 1990-08-01

Family

ID=23132503

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50886/90A Abandoned AU5088690A (en) 1989-01-06 1990-01-05 Keratoconjunctivitis cytotoxin and methods for its use and production

Country Status (2)

Country Link
AU (1) AU5088690A (en)
WO (1) WO1990007525A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012502A1 (en) * 1994-10-25 1996-05-02 Kansas State University Research Foundation Method of culturing m. bovis in low available iron media and production of infectious bovine keratoconjunctivitis vaccine therefrom
AUPQ257199A0 (en) 1999-08-31 1999-09-23 Commonwealth Scientific And Industrial Research Organisation Vaccine antigens of moraxella
US7220421B2 (en) * 2001-06-19 2007-05-22 The Regents Of The University Of California Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
US8858434B2 (en) 2004-07-13 2014-10-14 Dexcom, Inc. Transcutaneous analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines

Also Published As

Publication number Publication date
WO1990007525A1 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
AU616091B2 (en) Treatment process
AU5748990A (en) Venoscope
AU5176890A (en) Impedance cardiometer
AU5975590A (en) New substituted 1h-indazole-3-carboxamides
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
AU7750494A (en) Composites and methods for making same
AU4677089A (en) Chair
AU6673290A (en) Dipyridodiazepines
AU2843592A (en) 3,9-diphosphaspiroundecanes and process for making 3,9-diphosphaspiroundecanes
AU5302490A (en) Novel method and compounds
AU6596590A (en) Deoxyfluoronucleoside process
AU631622B2 (en) Snow-vehicle
AU6386390A (en) Therapeutic necleosides
AU5808490A (en) Vip-analogs 11
AU6183790A (en) Process for reducing the swellability of starches
AU1094588A (en) Novel preset necktie
AU4926190A (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use
AU628227B2 (en) Benzoxazinyl-pyrazoles, and their production and use
AU5088690A (en) Keratoconjunctivitis cytotoxin and methods for its use and production
AU6378790A (en) Process for producing norcamphane dicarbonitriles
AU637650B2 (en) 3-fluorosulfonyloxyceph-3-em displacement process
AU4817490A (en) 2',3'-dideoxyribofuranosides and process for producing them
AU6255690A (en) Opaliform porcellanite and process for the preparation thereof
AU6519190A (en) Tetrathiocarbonate process
AU6446190A (en) Process for inducing analgesia, peptides and therapeutic compositions